Gene · 3981
Papers3,259
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,259
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| C5aR1 and cGAS/STING and their possible involvement in radiosensitivity of colorectal cancer. | iScience | 2026 | 41809048 | PubTator, text mining | PubMed |
| Next Generation DNA Damage Response Inhibitors: Harnessing Nanocarriers and Tumor Microenvironment for Precision Cancer Therapy. | Oncol Res | 2026 | 41799521 | PubTator, text mining | PubMed |
| Caffeine inhibits nonhomologous end joining by impairing ligase IV/XRCC4 function. | Nucleic Acids Res | 2026 | 41773020 | PubTator, text mining | PubMed |
| Zinc finger proteins (ZFPs) in health and disease. | Mol Biomed | 2026 | 41772312 | PubTator, text mining | PubMed |
| Huntington's disease LIG1 modifier variant increases ligase fidelity and suppresses somatic CAG repeat expansion. | Proc Natl Acad Sci U S A | 2026 | 41770933 | PubTator, text mining | PubMed |
| Dysregulation of the DNA damage response by phosphorothioate antisense oligonucleotides. | Nat Commun | 2026 | 41760661 | PubTator, text mining | PubMed |
| Role of mitochondria in neuronal function and survival in the enteric and central nervous systems. | Cell Mol Life Sci | 2026 | 41746390 | PubTator, text mining | PubMed |
| First 2-year experience of nationwide newborn screening for severe forms of T and B cell immunodeficiency: 2.3 million newborns analyzed using TREC and KREC in Russia. | Front Immunol | 2026 | 41727503 | PubTator, text mining | PubMed |
| DNA polymerase λ autoinhibition is relieved via Ku interaction during non-homologous end joining. | Nucleic Acids Res | 2026 | 41700088 | PubTator, text mining | PubMed |
| Lead Exposure Triggers DNA Damage in TK6 Cells Via Alteration of DNA Repair Gene Expression and Hypermethylation of Ku80 Promoter Region. | Biol Trace Elem Res | 2026 | 41637007 | PubTator, text mining | PubMed |
| SUMOylation is destined for regulatory T cell-related immune dysregulation. | Cell Death Discov | 2026 | 41633969 | PubTator, text mining | PubMed |
| Impeding the NHEJ Pathway for Overcoming Radioresistance in the Context of Precision Radiotherapy of Cancer. | Pharmaceutics | 2026 | 41599238 | PubTator, text mining | PubMed |
| The role of HMGA1 in genome stability: Implications in human cancer. | Cell Mol Life Sci | 2026 | 41586900 | PubTator, text mining | PubMed |
| The SMC5/SMC6 complex is critical for resolving R-loop-induced transcription-replication conflicts. | Nucleic Acids Res | 2026 | 41533569 | PubTator, text mining | PubMed |
| BindFlow: A Free, User-Friendly Pipeline for Absolute Binding Free Energy Calculations Using Free Energy Perturbation or MM(PB/GB)SA. | J Chem Theory Comput | 2026 | 41498855 | PubTator, text mining | PubMed |
| Integrated case-control and in silico analysis of DNA double-strand break repair gene variants (RAD51, XRCC2, XRCC3, XRCC4, and LIG4) for ovarian cancer susceptibility. | Gene | 2026 | 41478437 | PubTator, text mining | PubMed |
| Exploring the Structural Dynamics of SRPK1 to Identify Competitive Inhibitors via Molecular Modeling Techniques. | Chemphyschem | 2026 | 41275410 | PubTator, text mining | PubMed |
| Nonhomologous end-joining uses distinct mechanisms to repair each strand of a double strand break. | Nat Commun | 2025 | 41285786 | PubTator, text mining | PubMed |
| The multiple layers of RNA response in double-strand break repair. | Exp Mol Med | 2025 | 41258079 | PubTator, text mining | PubMed |
| Anti-cancer compound screening identifies Aurora Kinase A inhibition as a means to favor CRISPR/Cas9 gene correction over knock-out. | PLoS One | 2025 | 41004518 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3981/papers?page=2